This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

10 Profitable and Oversold Stocks Ready To Move Higher

Stocks in this article: HPQ DELL ACI SWY BSX LVS KR TSN TIF TRW

Investors are receiving 46 cents in dividends for a yield of 2.18%.

Kroger's last quarterly earnings release was June 14, and the previous closing price was $22.58. Relative to a current price of $21.49, shares are down 2.3%.

Kroger is oversold on the daily chart and support on the weekly chart has held (so far) this week after a test.

I like the September $20 put during the next few trading days for 35 cents or greater. My profit target is 25 cents or close out on option expiration date. LVS Chart LVS data by YCharts

Las Vegas Sands (LVS)

Background:

The Sands is a hotel and casino, and trades an average of 10.7 million shares per day with a market cap of $30.9 billion.

52-week range: $36.71 to 61.05

Analysts are in love with this company. The Sands is sporting 19 buy or strong buy from a total of 21 analysts covering the company. The average analyst target price for LVS is $58.50.

The mean fiscal year estimate price-to-earnings ratio is 14.48, based on earnings of $2.65 per share this year. Investors are receiving $1 in dividends for a yield of 2.6%.

The Sands is oversold on the daily chart and support on the weekly chart is $29.80. The legal issues with Macau and the former head of a casino will darken the stock for a while.

I like the September $30 put during the next few trading days for 50 cents or more. My profit target is 35 cents or close out on option expiration date. BSX Chart BSX data by YCharts

Boston Scientific (BSX)

Background:

Boston Scientific trades an average of 10.9 million shares per day with a market cap of $7.6 billion.

52-week range: $5.09 to 7.28

The average analyst target price for Boston Scientific is $7.13.

The mean fiscal year estimate price-to-earnings ratio is 12.15, based on earnings of 43 cents per share this year.

The company has falling revenue year-over-year of $7.62 billion last fiscal year compared to $7.81 billion in the previous year. The bottom line has rising earnings year-over-year of $441 million last fiscal year compared to a loss of $1.07 billion in the previous year.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs